| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.039 | 0.8 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.8 |